Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis.
about
LeishVet guidelines for the practical management of canine leishmaniosisDiagnostic methods to cutaneous leishmaniasis detection in domestic dogs and catsUpdate on Canine and Feline Blood Donor Screening for Blood-Borne PathogensExposure to vector-borne pathogens in candidate blood donor and free-roaming dogs of northeast ItalyIdentification of Immunoreactive Leishmania infantum Protein Antigens to Asymptomatic Dog Sera through Combined Immunoproteomics and Bioinformatics AnalysisImmucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral LeishmaniasisProspective study on the incidence and progression of clinical signs in naïve dogs naturally infected by Leishmania infantumLaboratory tests for diagnosing and monitoring canine leishmaniasis.Immunologic indicators of clinical progression during canine Leishmania infantum infectionImmunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease.Dynamics and predictive potential of antibodies against insect-derived recombinant Leishmania infantum proteins during chemotherapy of naturally infected dogs.The protective immune response produced in dogs after primary vaccination with the LiESP/QA-21 vaccine (CaniLeish®) remains effective against an experimental challenge one year later.Evaluating the accuracy of molecular diagnostic testing for canine visceral leishmaniasis using latent class analysis.Prevalence and factors associated with Leishmania infantum infection of dogs from an urban area of Brazil as identified by molecular methodsAn in vitro model of antibody-enhanced killing of the intracellular parasite Leishmania amazonensisCanine skin and conjunctival swab samples for the detection and quantification of Leishmania infantum DNA in an endemic urban area in Brazil.Use of a LiESP/QA-21 vaccine (CaniLeish) stimulates an appropriate Th1-dominated cell-mediated immune response in dogs.A randomised, double-blind, controlled efficacy trial of the LiESP/QA-21 vaccine in naïve dogs exposed to two leishmania infantum transmission seasons.Humoral and in vivo cellular immunity against the raw insect-derived recombinant Leishmania infantum antigens KMPII, TRYP, LACK, and papLe22 in dogs from an endemic area.Application of qPCR in conjunctival swab samples for the evaluation of canine leishmaniasis in borderline cases or disease relapse and correlation with clinical parameters.Characterisation of the ex vivo virulence of Leishmania infantum isolates from Phlebotomus perniciosus from an outbreak of human leishmaniosis in Madrid, Spain.Nasal, oral and ear swabs for canine visceral leishmaniasis diagnosis: new practical approaches for detection of Leishmania infantum DNA.Development of a fluorescent based immunosensor for the serodiagnosis of canine leishmaniasis combining immunomagnetic separation and flow cytometry.Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments.The first report of autochthonous non-vector-borne transmission of canine leishmaniosis in the Nordic countries.Methods of Control of the Leishmania infantum Dog Reservoir: State of the Art.The prevalence of canine Leishmania infantum infection in Sichuan Province, southwestern China detected by real time PCR.Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis.LeishVet update and recommendations on feline leishmaniosis.Histopathological and parasitological study of the gastrointestinal tract of dogs naturally infected with Leishmania infantum.A Novel Molecular Test to Diagnose Canine Visceral Leishmaniasis at the Point of Care.Transcription of Toll-Like Receptors 2, 3, 4 and 9, FoxP3 and Th17 Cytokines in a Susceptible Experimental Model of Canine Leishmania infantum Infection.An immune-modulating diet increases the regulatory T cells and reduces T helper 1 inflammatory response in Leishmaniosis affected dogs treated with standard therapy.Efficacy of combined therapy with liposome-encapsulated meglumine antimoniate and allopurinol in treatment of canine visceral leishmaniasisCanine and feline parasitic zoonoses in China.Evaluation of various biomarkers for kidney monitoring during canine leishmaniosis treatmentImmunogenicity in dogs and protection against visceral leishmaniasis induced by a 14kDa Leishmania infantum recombinant polypeptide.Clinical, hematological and biochemical alterations in hamster (Mesocricetus auratus) experimentally infected with Leishmania infantum through different routes of inoculation.Seropositivity rates for agents of canine vector-borne diseases in Spain: a multicentre study.
P2860
Q21198917-616AB0F7-B568-4D7F-98B3-0CF17F07C39EQ26770463-3CBCC219-316A-48A1-8A97-979A2548979CQ26775073-0BE4D901-4724-4318-A312-C369F8765061Q27469015-6F4C3797-DBC3-4D7E-BEBB-5333A5735D09Q28550337-AF58A0FE-E4BF-49FE-851F-D7A48F13D4D1Q28551736-B2574F89-C016-4712-9C80-FE0AC7AAEEFEQ33407755-7853F05F-A625-43D8-BE1B-56686993C408Q33436487-1CFF2675-1D36-430B-90C6-C10CBEBFBC25Q33627078-4A2EA551-A613-4F52-96E0-786E8822447EQ33749424-2E652095-87F7-4A13-8BD4-415F7F65BB6BQ33817557-21DDB0ED-EF0A-40D5-92E4-CC88F9B21882Q33861384-7996B82F-35EF-47A5-BCC0-82979B10237AQ33975650-864C2FD7-7892-4558-9F31-9CBC8447716BQ34000134-3AA93311-0B48-4666-A72C-5E4850A395D7Q34142338-625E6D21-5E13-4379-9AFC-70A42CA3E2B4Q34233909-5C6CEC4C-ED4B-461D-ABD0-62E8E15B42C5Q34314496-B2E82B25-053E-4F8D-9688-0275DF2F6EADQ34315159-337AD399-4D6C-4655-9F00-B2FF92BEE26DQ34341852-CE10704F-5B1B-4A12-9CEC-2E3114412B90Q34394675-BAD26CE3-2452-4F91-AB0D-2407CEB42951Q34499462-822E72D4-8280-4424-91C2-8883AB62CA14Q34675093-EC61DE1B-A79F-4C2D-994C-DF0D1EF6A6F5Q34977153-F2AA3C0C-CEE7-4809-8AD8-CC81837B9D7EQ34980884-BF96BE6F-AD3E-438B-9806-070AEB84C5E5Q35025544-A03C601D-710D-453D-9646-2E2325ED7467Q35101238-FE678FA8-C2B5-4260-8264-E7646CAF8504Q35230422-6165A8ED-0929-467F-9A28-2229B9B75302Q35690135-D92952DB-25B9-4F3B-9DB6-F4EB6492565AQ35702943-94B8A323-0659-4B74-98C7-FC29178BDAFCQ35711917-B37ADCEA-BB45-43D6-BB2B-B20AA5667D0DQ35717351-6E90C8A0-C4F2-4C29-AC0F-DF92A3527B9AQ35736705-5A391CC8-7D6F-4B8C-9F6A-5089E8F52B7CQ35806436-002290FE-3511-45DC-BC34-AFA299E08B21Q35860511-98B280AE-5EDE-4A38-B1C4-0D966BC472FFQ36018707-BD591AEE-A9A4-46C9-BAF2-659763682C5BQ36200720-805EBA31-73FF-45F7-AC9F-5A176691C218Q36258015-DAEA74E5-08DC-4112-B626-ED5024F2F472Q36340603-26CAB7CB-DF14-481A-8D4F-3123C89F0CDAQ36749036-1AB2B3D4-5997-423B-8E12-7A1C0643868AQ36803346-BA9A5462-53FF-427A-8799-BB76C36F17B9
P2860
Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Directions for the diagnosis, ...... ntion of canine leishmaniosis.
@en
Directions for the diagnosis, ...... ntion of canine leishmaniosis.
@nl
type
label
Directions for the diagnosis, ...... ntion of canine leishmaniosis.
@en
Directions for the diagnosis, ...... ntion of canine leishmaniosis.
@nl
prefLabel
Directions for the diagnosis, ...... ntion of canine leishmaniosis.
@en
Directions for the diagnosis, ...... ntion of canine leishmaniosis.
@nl
P2093
P50
P1476
Directions for the diagnosis, ...... ention of canine leishmaniosis
@en
P2093
A Koutinas
L Solano-Gallego
M G Pennisi
P Bourdeau
P356
10.1016/J.VETPAR.2009.05.022
P577
2009-06-06T00:00:00Z